ENvue Medical's stock surged 135.67% to $2.47 following a 1-for-10 reverse split completed in early December 2025, powered by a strategic distribution milestone. The company has secured a partnership with U-Deliver, a leading supplier in the home and long-term care space, to expand nationwide availability of its reusable syringe offerings.



ENvue specializes in non-invasive enteral care solutions for both clinical and home settings. The newly forged deal with U-Deliver targets the underserved non-acute care market, where demand for accessible and affordable feeding solutions continues to grow. Through this collaboration, the reusable syringe line will be distributed via U-Deliver's digital channels, Amazon marketplace, and wholesale network—a significant expansion beyond traditional hospital channels.

The centerpiece of this partnership is ENvue's reusable ENFit syringe collection, engineered for sustainability and cost efficiency. Available in four sizes (2.5mL, 5mL, 10mL, and 60mL), these reusable syringes meet ISO 80369-3 global standards and maintain functionality for up to seven days or 20 uses—a major advantage over single-use alternatives. This reusable design aligns with the growing push toward sustainable medical products while reducing overall patient and caregiver expenses.

For U-Deliver, the partnership strengthens its mission to simplify tube-feeding needs through accessible, high-quality products. By offering prescription-free reusable syringes, both companies are positioning themselves at the intersection of healthcare innovation and practical affordability—an attractive positioning in the expanding home care market where operational costs matter significantly.

The move marks ENvue's aggressive push into the non-acute care segment, where reusable medical devices are increasingly preferred over disposable alternatives. With U-Deliver's established distribution infrastructure and digital presence, ENvue gains rapid market penetration across home healthcare providers and individual consumers nationwide.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)